Author Archives: Steve Walker

Medical stocks resemble Mr. Toad’s Wild Ride with brave investors tightening their seat belts and neck braces for more uncertainty, price fluctuation.

Health-sector stocks were whipsawed upward, downward, backward and forward last week, rekindling memories of the Yardbirds’ hit song in the 60’s with a similar name. Still, when the dust settled,… Read more »

Close (but not too close) encounters with God confer mental health benefits, say researchers at Johns Hopkins. This definitely isn’t your typical medical article.

The News: Profound religious experiences are linked to lasting mental health benefits, new research suggests. In a survey study of more than 4000 individuals, those who reported having profound personal… Read more »

Seven health-sector IPOs do the limbo and raise $499M, seconds before market falls off a cliff.

Trade war fears are crushing stocks, and the their swan dive onto the rocks could keep going if Presidents Trump and China’s Xi Jinping keep tossing tariff grenades at each… Read more »

Healthcare IPOs still on a tear as pricings and registrations keep Wall Street, SEC on their toes.

Despite President Trump’s threatening trade Tweets to China and the resulting drag on stocks, only the health sector came out ahead on Monday (May 6, 2019), and the IPO action… Read more »

Healthcare stocks continue rise from the ashes as legislative uncertainties wane; sanity, fundamentals return.

Several Democratic presidential candidates have embraced “Medicare for all” as a rallying cry. Others are calling for a variety of healthcare reforms, such as lowering Medicare’s eligibility age from the… Read more »

Health-sector IPO action defies market jitters as Q1 earnings, the Federal Reserve and China trade talks take front stage.

Undaunted by the crushing weight of uncertainty affecting healthcare stock prices lately, the IPO action in New York continues to race ahead as though determined to prove Hong Kong’s budding… Read more »

Health stocks mount furious comeback after getting crushed by jitters about Medicare for All, the fate of the ACA and threats of new drug-pricing rules.

Here we go again. The S&P 500 healthcare sector fell 4.4% two weeks ago, its worst weekly decline since late December. The move ended with more than 93% of healthcare stocks trading… Read more »

Europe, sans Basel, Copenhagen and Paris, taking on the US biotech titans.

The News: Since its birthday back in 1776, America has seen itself as the land of the new–and Europe as a landmass caught in the past. Nowhere is that truer… Read more »